Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0129 USD | 0.00% | -4.44% | -93.38% |
Mar. 20 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index | CI |
Mar. 15 | Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from NASDAQ Composite Index | CI |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | 3.8M | Capitalization | 703K |
---|---|---|---|---|---|
Net income 2023 * | -28M | Net income 2024 * | -47M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 0.19 x |
P/E ratio 2023 * |
-0.02
x | P/E ratio 2024 * |
-0.01
x | Employees | 54 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 51.23% |
Latest transcript on Better Therapeutics, Inc.
1 week | -4.44% | ||
Current month | -91.87% | ||
1 month | -92.28% | ||
3 months | -93.06% | ||
6 months | -96.25% | ||
Current year | -93.38% |
Managers | Title | Age | Since |
---|---|---|---|
Andres Camacho
CTO | Chief Tech/Sci/R&D Officer | - | - |
Leslie Miller
AUD | Comptroller/Controller/Auditor | 43 | 21-09-30 |
Corporate Officer/Principal | - | 22-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.0129 | 0.00% | 412 492 |
24-03-27 | 0.0129 | -5.84% | 620,586 |
24-03-26 | 0.0137 | -21.71% | 1,637,871 |
24-03-25 | 0.0175 | -14.95% | 1,121,041 |
24-03-22 | 0.0206 | +52.41% | 2,352,431 |
Delayed Quote OTC Markets, March 28, 2024 at 11:22 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.38% | 703K | |
+9.31% | 45.97B | |
+52.78% | 43.93B | |
+8.27% | 42.34B | |
-8.78% | 28.27B | |
+17.98% | 27.18B | |
-20.93% | 19.44B | |
+14.44% | 13.83B | |
+32.12% | 12.4B | |
+9.70% | 11.45B |